Amphastar Pharmaceuticals (AMPH) Common Equity (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Common Equity of $773.4 million for Q1 2026, up 2.94% year-over-year from $751.3 million in Q1 2025, and down 1.95% quarter-over-quarter from $788.8 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Common Equity (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Common Equity history runs 14 years deep, the most recent figure standing at $773.4 million for Q1 2026.
- In Q1 2026, Common Equity rose 2.94% year-over-year to $773.4 million; the TTM figure through Mar 2026 stood at $773.4 million (up 2.94% YoY), while the FY2025 annual figure was $788.8 million, up 7.72% from the prior year.
- Common Equity for Q1 2026 stood at $773.4 million, down from $788.8 million in the prior quarter.
- The five-year high for Common Equity was $788.8 million in Q4 2025, with the low at $479.5 million in Q1 2022.
- The 5-year median for Common Equity is $672.4 million (2024), against an average of $651.7 million.
- The sharpest annual moves came in 2024 and 2026: Common Equity gained 22.56% in 2024, then grew 2.94% in 2026.
- Amphastar Pharmaceuticals' Common Equity stood at $528.7 million in 2022, then increased by 20.95% to $639.4 million in 2023, then rose by 14.53% to $732.3 million in 2024, then increased by 7.72% to $788.8 million in 2025, then dropped by 1.95% to $773.4 million in 2026.
- Business Quant data shows AMPH's Common Equity at $773.4 million in Q1 2026, $788.8 million in Q4 2025, and $776.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 4.05 Bn |
| 10 | Amphastar Pharmaceuticals | 942.71 Mn | 652.59 Mn | 93.47 Mn | 768.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 768.16 Mn |
| Mar 31, 2026 | 773.39 Mn |
| Dec 31, 2025 | 788.81 Mn |
| Sep 30, 2025 | 776.75 Mn |
| Jun 30, 2025 | 757.48 Mn |
| Mar 31, 2025 | 751.28 Mn |
| Dec 31, 2024 | 732.30 Mn |
| Sep 30, 2024 | 727.68 Mn |
| Jun 30, 2024 | 713.35 Mn |
| Mar 31, 2024 | 672.36 Mn |
| Dec 31, 2023 | 639.42 Mn |
| Sep 30, 2023 | 595.14 Mn |
| Jun 30, 2023 | 589.24 Mn |
| Mar 31, 2023 | 548.58 Mn |
| Dec 31, 2022 | 528.66 Mn |
| Sep 30, 2022 | 505.17 Mn |
| Jun 30, 2022 | 499.31 Mn |
| Mar 31, 2022 | 479.53 Mn |
| Dec 31, 2021 | 445.52 Mn |
| Sep 30, 2021 | 430.18 Mn |